F. Hoffmann-La Roche Ltd (ROG):企業の財務・戦略的SWOT分析

◆英語タイトル:F. Hoffmann-La Roche Ltd (ROG) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1350
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:94
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,125見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,375見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

F. Hoffmann-La Roche Ltd (ROG) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

F. Hoffmann-La Roche Ltd (Roche) is a biotechnology company that develops drugs and diagnostics to treat major diseases. It provides pharmaceuticals in oncology, immunology, neuroscience, ophthalmology, infectious diseases, respiratory and other therapeutic areas. The company also provides in vitro diagnostics and tissue-based cancer diagnostics, besides diabetes management solutions. Roche conducts research to identify novel methods to prevent, diagnose and treat diseases. The company offers its products and services to hospitals, commercial laboratories, healthcare professionals, researchers and pharmacists. Together with its subsidiaries and partners, the company has operations in various countries all over the world. Roche is headquartered in Basel, Switzerland.

F. Hoffmann-La Roche Ltd Key Recent Developments

Mar 31,2020: Roche Canada establishes COVID-19 Open Innovation Challenge
Mar 30,2020: Outlook on the Global Non-Invasive Prenatal Testing Market to 2027 – Featuring PerkinElmer, Natera & F. Hoffman La Roche Among Others – ResearchAndMarkets.com
Mar 24,2020: Roche urges international collaboration to tackle Covid-19 pandemic
Mar 24,2020: Roche response to COVID-19 pandemic
Mar 14,2020: Roche Annual General Meeting 2020 to take place Annual General Meeting on 17 March 2020 will take place as planned under conditions set by the authorities in SwitzerlandRoche strongly advises against physical participation a

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
F. Hoffmann-La Roche Ltd – Key Facts
F. Hoffmann-La Roche Ltd – Key Employees
F. Hoffmann-La Roche Ltd – Key Employee Biographies
F. Hoffmann-La Roche Ltd – Major Products and Services
F. Hoffmann-La Roche Ltd – History
F. Hoffmann-La Roche Ltd – Company Statement
F. Hoffmann-La Roche Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Affiliate
Section 2 – Company Analysis
Company Overview
F. Hoffmann-La Roche Ltd – Business Description
Business Segment: Diagnostics
Overview
Performance
Key Stats
Business Segment: Pharmaceuticals
Overview
Performance
Key Stats
Geographical Segment: Africa, Australia and Oceania
Performance
Geographical Segment: Asia
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Latin America
Performance
Geographical Segment: North America
Performance
R&D Overview
F. Hoffmann-La Roche Ltd – Corporate Strategy
F. Hoffmann-La Roche Ltd – SWOT Analysis
SWOT Analysis – Overview
F. Hoffmann-La Roche Ltd – Strengths
F. Hoffmann-La Roche Ltd – Weaknesses
F. Hoffmann-La Roche Ltd – Opportunities
F. Hoffmann-La Roche Ltd – Threats
F. Hoffmann-La Roche Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
F. Hoffmann-La Roche Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
F. Hoffmann-La Roche Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
F. Hoffmann-La Roche Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 31, 2020: Roche Canada establishes COVID-19 Open Innovation Challenge
Mar 24, 2020: Roche urges international collaboration to tackle Covid-19 pandemic
Mar 24, 2020: Roche response to COVID-19 pandemic
Mar 05, 2020: Roche wins Chinese approval for Actemra to combat coronavirus complications
Feb 28, 2020: FinnGen grows to one of the largest private-public studies in the world
Feb 27, 2020: Roche to invest in Cape Town site to accommodate rapid growth and future expansion for its Diagnostics business
Feb 27, 2020: Three patients in Ascletis Pharma coronavirus pneumonia study discharged
Feb 21, 2020: Leaders from 24 companies in the US Pharmaceutical Supply Chain collaborate to submit the MediLedger DSCSA Pilot Project Final Report to the FDA, proposing blockchain for an interoperable track and trace system for US prescription drugs
Feb 20, 2020: Roche presents RocheDiabetes InsulinStart, a new service for an easy start to insulin therapy
Jan 30, 2020: Roche reports very strong results in 2019
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
F. Hoffmann-La Roche Ltd, Key Facts
F. Hoffmann-La Roche Ltd, Key Employees
F. Hoffmann-La Roche Ltd, Key Employee Biographies
F. Hoffmann-La Roche Ltd, Major Products and Services
F. Hoffmann-La Roche Ltd, History
F. Hoffmann-La Roche Ltd, Subsidiaries
F. Hoffmann-La Roche Ltd, Affiliate
F. Hoffmann-La Roche Ltd, Key Competitors
F. Hoffmann-La Roche Ltd, Ratios based on current share price
F. Hoffmann-La Roche Ltd, Annual Ratios
F. Hoffmann-La Roche Ltd, Annual Ratios (Cont...1)
F. Hoffmann-La Roche Ltd, Annual Ratios (Cont...2)
F. Hoffmann-La Roche Ltd, Interim Ratios
F. Hoffmann-La Roche Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
F. Hoffmann-La Roche Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
F. Hoffmann-La Roche Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
F. Hoffmann-La Roche Ltd, Performance Chart (2015 - 2019)
F. Hoffmann-La Roche Ltd, Ratio Charts
F. Hoffmann-La Roche Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
F. Hoffmann-La Roche Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[F. Hoffmann-La Roche Ltd (ROG):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Haisco Pharmaceutical Group Co Ltd (002653)-医療機器分野:企業M&A・提携分析
    Summary Haisco Pharmaceutical Group Co Ltd (Haisco Pharma), formerly Xizang Haisco Pharmaceutical Group Co Ltd is a developer and marketer of chemical drug preparations and bulk drugs. The company's product portfolio comprises injection for trace elements, compound vitamin, invert sugar, fat soluble …
  • TOA Corporation:企業の戦略・SWOT・財務分析
    TOA Corporation - Strategy, SWOT and Corporate Finance Report Summary TOA Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • JetBlue Airways Corp:企業の戦略・SWOT・財務情報
    JetBlue Airways Corp - Strategy, SWOT and Corporate Finance Report Summary JetBlue Airways Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Ulker Biskuvi Sanayi A.S.:企業の戦略・SWOT・財務情報
    Ulker Biskuvi Sanayi A.S. - Strategy, SWOT and Corporate Finance Report Summary Ulker Biskuvi Sanayi A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • EOG Resources Inc (EOG):石油・ガス:M&Aディール及び事業提携情報
    Summary EOG Resources Inc (EOG) is an independent upstream oil and gas company. The company, along with its subsidiaries, explores for, develops and produces crude oil and natural gas. EOG has operations in the US, Canada, Trinidad, the UK and China. Its holds licenses for assets in in Eagle Ford, B …
  • Xtant Medical Holdings Inc (XTNT):製薬・医療:M&Aディール及び事業提携情報
    Summary Xtant Medical Holdings Inc (Xtant Medical), formerly Bacterin International Holdings Inc, is a medical device company that develops regenerative medicine products and medical devices. The company’s products include 3Demin, osteosponge, osteosponge SC, osteoselect DBM Putty, OsteoSTX, osteowr …
  • New Zealand Pharmaceuticals Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary New Zealand Pharmaceuticals Ltd (NZP) a subsidiary of Archer Capital, manufactures and supplies pharmaceutical intermediates and diagnostic products for pharmaceutical and microbiological media companies. It also offers biochemicals and natural extracts for health, cosmetic, biotechnology, f …
  • Georgetown University-製薬・医療分野:企業M&A・提携分析
    Summary Georgetown University (GU) is an academic and research institution which offers educational services. It provides undergraduate and graduate degree programs in the fields of law, medical, medical residencies, business administration and public policy degrees, post-doctoral positions, special …
  • Canadian Overseas Petroleum Ltd (XOP):石油・ガス:M&Aディール及び事業提携情報
    Summary Canadian Overseas Petroleum Ltd (COPL), formerly Velo Energy Inc is an oil and gas company that offers exploration and production of crude oil and natural gas properties. The company operates single well unappraised discoveries in mature basins and bringing them into production. Its projects …
  • Guangxi Investment Group Co Ltd:電力:M&Aディール及び事業提携情報
    Summary Guangxi Investment Group Co Ltd (Guangxi Investment) is a diversified company. The company’s business segments include energy, aluminium, financial, cultural tourism, international business and medical and medical health business. Its energy business provides investments in the construction …
  • Nissan Chemical Corp (4021):企業の財務・戦略的SWOT分析
    Nissan Chemical Corp (4021) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Citation Oil & Gas Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary Citation Oil & Gas Corp (Citation) is an oil and gas exploration company that acquires, produces, and develops oil and gas properties. The company's products include natural gas, NGL, crude oil, and coalbed methane gas. It conducts asset development program for production and recoverable res …
  • Saxo Bank A/S:企業のM&A・事業提携・投資動向
    Saxo Bank A/S - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Saxo Bank A/S Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Centrica Plc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Centrica Plc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Centrica Plc (Centrica) is an integrated energy company. It carries out electricity generation through and combined cycle gas turbine (CCGT) power stations, and nuclear power plants through its stake in EDF …
  • RattanIndia Power Ltd (RTNPOWER):電力:M&Aディール及び事業提携情報
    Summary RattanIndia Power Ltd (RattanIndia Power), formerly Sophia Power Company Ltd is a power company that constructs, develops, operates, and manages thermal power projects across India. The company offers renewable energy solutions, operation and management of power plants, and project managemen …
  • Oleo e Gas Participacoes SA (OGXP3):企業の財務・戦略的SWOT分析
    Summary Oleo e Gas Participacoes SA (OGX) is an oil and gas company that acquires and explores for oil and natural gas properties. The company operates a diversified portfolio of exploratory blocks located in offshore sedimentary basins in Brazil. It operates blocks located in onshore sedimentary ba …
  • Active Motif Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Active Motif Inc (Active Motif) is a healthcare company that develops and delivers biological research tools. The company’s products include extracts, antibodies, reporter assays, fluorescent dyes, kits, cell, acid, and tissue extracts, molecules and recombinant proteins, among others. It of …
  • AMC Airlines:企業の戦略・SWOT・財務情報
    AMC Airlines - Strategy, SWOT and Corporate Finance Report Summary AMC Airlines - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Danone SA:企業の戦略・SWOT・財務情報
    Danone SA - Strategy, SWOT and Corporate Finance Report Summary Danone SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • EOS imaging SA (EOSI):企業の財務・戦略的SWOT分析
    EOS imaging SA (EOSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆